Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2015 - 2018)
Teva Pharmaceutical Industries' (TEVA) quarterly Preferred Dividend Payments came in at $54.0 million in Q4 2018, down 16.92% YoY from $65.0 million in Q4 2017, and down 16.92% on a QoQ basis from $65.0 million in Q3 2018.
Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2015 - 2018) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 4 years of Preferred Dividend Payments data on file, last reported at $54.0 million in Q4 2018.
- Quarterly Preferred Dividend Payments fell 16.92% year-over-year to $54.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $249.0 million (down 4.23% YoY) and the FY2018 annual result came in at $249.0 million, down 4.23% from the prior year.
- Preferred Dividend Payments declined to $54.0 million in Q4 2018, from $65.0 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $66.0 million in Q1 2016 to a low of $15.0 million in Q4 2015.
- A 4-year average of $60.4 million and a median of $65.0 million in 2016 frame the typical range for Preferred Dividend Payments.
- Annual changes were most pronounced in 2016 — Preferred Dividend Payments jumped 333.33% — and 2018, when it dropped 16.92%.
- Tracing TEVA's Preferred Dividend Payments over 4 years: stood at $15.0 million in 2015, then jumped by 333.33% to $65.0 million in 2016, then changed by 0.0% to $65.0 million in 2017, then retreated by 16.92% to $54.0 million in 2018.
- The last three Preferred Dividend Payments figures came in at $54.0 million (Q4 2018), $65.0 million (Q3 2018), and $65.0 million (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 54.00 Mn |
| Sep 30, 2018 | 65.00 Mn |
| Jun 30, 2018 | 65.00 Mn |
| Mar 31, 2018 | 65.00 Mn |
| Dec 31, 2017 | 65.00 Mn |
| Sep 30, 2017 | 65.00 Mn |
| Jun 30, 2017 | 65.00 Mn |
| Mar 31, 2017 | 65.00 Mn |
| Dec 31, 2016 | 65.00 Mn |
| Sep 30, 2016 | 64.00 Mn |
| Jun 30, 2016 | 66.00 Mn |
| Mar 31, 2016 | 66.00 Mn |
| Dec 31, 2015 | 15.00 Mn |